Global Gastrointestinal Drugs Competitive Landscape Professional Research Report 2025
Description
Global Gastrointestinal Drugs Competitive Landscape Professional Research Report 2025
Research Summary
Gastrointestinal (GI) drugs are medications designed to treat disorders and diseases affecting the digestive system, which includes the stomach, intestines, and associated organs. These drugs address a wide range of conditions such as acid reflux, peptic ulcers, irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), constipation, diarrhea, and nausea. Common classes of GI drugs include antacids, proton pump inhibitors (PPIs), H2-receptor antagonists, laxatives, antidiarrheals, antiemetics, and antispasmodics. For instance, antacids and PPIs are used to reduce stomach acid and relieve symptoms of heartburn and acid reflux, while laxatives help alleviate constipation by promoting bowel movements. These medications can be available over-the-counter or by prescription, depending on their strength and specific use. Gastrointestinal drugs play a crucial role in improving the quality of life for patients by managing symptoms, promoting healing, and preventing complications associated with GI disorders.
According to DIResearch's in-depth investigation and research, the global Gastrointestinal Drugs market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Gastrointestinal Drugs include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria (Tillotts), Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Gastrointestinal Drugs. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gastrointestinal Drugs market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Gastrointestinal Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gastrointestinal Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Gastrointestinal Drugs Include:
AstraZeneca
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria (Tillotts)
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian-Janssen
Gastrointestinal Drugs Product Segment Include:
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Gastrointestinal Drugs Product Application Include:
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Gastrointestinal Drugs Industry PESTEL Analysis
Chapter 3: Global Gastrointestinal Drugs Industry Porter’s Five Forces Analysis
Chapter 4: Global Gastrointestinal Drugs Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Gastrointestinal Drugs Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Gastrointestinal Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Gastrointestinal Drugs Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Gastrointestinal Drugs Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Gastrointestinal Drugs Product by Type
- 1.2.1 Prescription Gastrointestinal Drug
- 1.2.2 OTC Gastrointestinal Drug
- 1.3 Gastrointestinal Drugs Product by Application
- 1.3.1 Chronic Gastritis
- 1.3.2 Functional Dyspepsia
- 1.3.3 Peptic Ulcer
- 1.3.4 Acute Gastroenteritis
- 1.3.5 Others
- 1.4 Global Gastrointestinal Drugs Market Revenue and Sales Analysis
- 1.4.1 Global Gastrointestinal Drugs Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Gastrointestinal Drugs Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Gastrointestinal Drugs Market Sales Price Trend Analysis (2020-2032)
- 1.5 Gastrointestinal Drugs Industry Trends and Innovation
- 1.5.1 Gastrointestinal Drugs Industry Trends and Innovation
- 1.5.2 Gastrointestinal Drugs Market Drivers and Challenges
- 2 Gastrointestinal Drugs Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Gastrointestinal Drugs Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Gastrointestinal Drugs Market Analysis by Regions
- 4.1 Gastrointestinal Drugs Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Gastrointestinal Drugs Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Gastrointestinal Drugs Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Gastrointestinal Drugs Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Gastrointestinal Drugs Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Gastrointestinal Drugs Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Gastrointestinal Drugs Sales Forecast by Region (2026-2032)
- 4.4 Global Gastrointestinal Drugs Sales Price Trend Analysis (2020-2032)
- 5 Global Gastrointestinal Drugs Market Size by Type and Application
- 5.1 Global Gastrointestinal Drugs Market Size by Type
- 5.1.1 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Gastrointestinal Drugs Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Gastrointestinal Drugs Market Size by Application
- 5.2.1 Global Gastrointestinal Drugs Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Gastrointestinal Drugs Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Gastrointestinal Drugs Market Size by Type
- 6.3.1 North America Gastrointestinal Drugs Sales by Type (2020-2032)
- 6.3.2 North America Gastrointestinal Drugs Revenue by Type (2020-2032)
- 6.4 North America Gastrointestinal Drugs Market Size by Application
- 6.4.1 North America Gastrointestinal Drugs Sales by Application (2020-2032)
- 6.4.2 North America Gastrointestinal Drugs Revenue by Application (2020-2032)
- 6.5 North America Gastrointestinal Drugs Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Gastrointestinal Drugs Market Size by Type
- 7.3.1 Europe Gastrointestinal Drugs Sales by Type (2020-2032)
- 7.3.2 Europe Gastrointestinal Drugs Revenue by Type (2020-2032)
- 7.4 Europe Gastrointestinal Drugs Market Size by Application
- 7.4.1 Europe Gastrointestinal Drugs Sales by Application (2020-2032)
- 7.4.2 Europe Gastrointestinal Drugs Revenue by Application (2020-2032)
- 7.5 Europe Gastrointestinal Drugs Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Gastrointestinal Drugs Market Size by Type
- 8.3.1 China Gastrointestinal Drugs Sales by Type (2020-2032)
- 8.3.2 China Gastrointestinal Drugs Revenue by Type (2020-2032)
- 8.4 China Gastrointestinal Drugs Market Size by Application
- 8.4.1 China Gastrointestinal Drugs Sales by Application (2020-2032)
- 8.4.2 China Gastrointestinal Drugs Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Gastrointestinal Drugs Market Size by Type
- 9.3.1 APAC (excl. China) Gastrointestinal Drugs Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Gastrointestinal Drugs Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Gastrointestinal Drugs Market Size by Application
- 9.4.1 APAC (excl. China) Gastrointestinal Drugs Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Gastrointestinal Drugs Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Gastrointestinal Drugs Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Gastrointestinal Drugs Market Size by Type
- 10.3.1 Latin America Gastrointestinal Drugs Sales by Type (2020-2032)
- 10.3.2 Latin America Gastrointestinal Drugs Revenue by Type (2020-2032)
- 10.4 Latin America Gastrointestinal Drugs Market Size by Application
- 10.4.1 Latin America Gastrointestinal Drugs Sales by Application (2020-2032)
- 10.4.2 Latin America Gastrointestinal Drugs Revenue by Application (2020-2032)
- 10.5 Latin America Gastrointestinal Drugs Market Size by Country
- 10.6 Latin America Gastrointestinal Drugs Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Gastrointestinal Drugs Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Gastrointestinal Drugs Market Size by Type
- 11.3.1 Middle East & Africa Gastrointestinal Drugs Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Gastrointestinal Drugs Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Gastrointestinal Drugs Market Size by Application
- 11.4.1 Middle East & Africa Gastrointestinal Drugs Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Gastrointestinal Drugs Revenue by Application (2020-2032)
- 11.5 Middle East Gastrointestinal Drugs Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Gastrointestinal Drugs Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Gastrointestinal Drugs Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Gastrointestinal Drugs Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Gastrointestinal Drugs Average Sales Price by Manufacturers (2021-2025)
- 12.2 Gastrointestinal Drugs Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Gastrointestinal Drugs Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AstraZeneca
- 13.1.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AstraZeneca Gastrointestinal Drugs Product Portfolio
- 13.1.3 AstraZeneca Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Sanofi
- 13.2.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Sanofi Gastrointestinal Drugs Product Portfolio
- 13.2.3 Sanofi Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 Bayer
- 13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bayer Gastrointestinal Drugs Product Portfolio
- 13.3.3 Bayer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Pfizer
- 13.4.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Pfizer Gastrointestinal Drugs Product Portfolio
- 13.4.3 Pfizer Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 GlaxoSmithKline
- 13.5.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 GlaxoSmithKline Gastrointestinal Drugs Product Portfolio
- 13.5.3 GlaxoSmithKline Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Teva
- 13.6.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Teva Gastrointestinal Drugs Product Portfolio
- 13.6.3 Teva Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Zeria (Tillotts)
- 13.7.1 Zeria (Tillotts) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Zeria (Tillotts) Gastrointestinal Drugs Product Portfolio
- 13.7.3 Zeria (Tillotts) Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Perrigo
- 13.8.1 Perrigo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Perrigo Gastrointestinal Drugs Product Portfolio
- 13.8.3 Perrigo Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Boehringer Ingelheim
- 13.9.1 Boehringer Ingelheim Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Boehringer Ingelheim Gastrointestinal Drugs Product Portfolio
- 13.9.3 Boehringer Ingelheim Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Purdue Pharma
- 13.10.1 Purdue Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Purdue Pharma Gastrointestinal Drugs Product Portfolio
- 13.10.3 Purdue Pharma Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 C.B. Fleet
- 13.11.1 C.B. Fleet Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 C.B. Fleet Gastrointestinal Drugs Product Portfolio
- 13.11.3 C.B. Fleet Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.12 Abbott
- 13.12.1 Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Abbott Gastrointestinal Drugs Product Portfolio
- 13.12.3 Abbott Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.13 Jiangzhong
- 13.13.1 Jiangzhong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Jiangzhong Gastrointestinal Drugs Product Portfolio
- 13.13.3 Jiangzhong Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.14 Xian-Janssen
- 13.14.1 Xian-Janssen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Xian-Janssen Gastrointestinal Drugs Product Portfolio
- 13.14.3 Xian-Janssen Gastrointestinal Drugs Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Gastrointestinal Drugs Industry Chain Analysis
- 14.2 Gastrointestinal Drugs Industry Raw Material and Suppliers Analysis
- 14.2.1 Gastrointestinal Drugs Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Gastrointestinal Drugs Typical Downstream Customers
- 14.4 Gastrointestinal Drugs Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
